ACS applied materials & interfaces

European journal of medicinal chemistry

Bioorganic chemistry

molecules and cells

febs open bio

Environmental science & technology

colloids and surfaces b, biointerfaces

anti-cancer agents in medicinal chemistry

iubmb life

The Journal of investigative dermatology

molecular biology reports

toxicological sciences : an official journal of the society of toxicology

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

open access macedonian journal of medical sciences

Gene

Cell reports

emerging microbes & infections

Frontiers in oncology

molecular systems biology

cancer letters

environmental toxicology

Drug and chemical toxicology

the american journal of surgical pathology

Pathogens and disease

differentiation; research in biological diversity

journal of pediatric hematology/oncology

journal of pathology and translational medicine

the kaohsiung journal of medical sciences

Zhongguo zhen jiu = Chinese acupuncture & moxibustion

Cancer Discovery

ophthalmic plastic and reconstructive surgery

international journal of clinical and experimental pathology

genes & development

[1] Molecular and Clinicopathological Features of Gastrointestinal Stromal tumors of Vietnamese Patients.

[2] Peritoneal Fluid Cytology of Disseminated Large Cell Neuroendocrine Carcinoma Combined with Endometrioid Adenocarcinoma of the Endometrium.

[3] p53 pulse modulation differentially regulates target gene promoters to regulate cell fate decisions.

[4] Disordered p53-MALAT1 pathway is associated with recurrent miscarriage.

[5] Effect of p53 Arg72Pro polymorphism on the induction of micronucleus by aflatoxin B1 in in vitro in human blood lymphocytes.

[6] Effect of high-risk human papillomavirus in esophageal squamous cell carcinoma in Somalian and Turkish cases.

[7] The role of acetylation sites in the regulation of p53 activity.

[8] The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.

[9] Clinicopathological Characterization of Children With B-Cell Non-Hodgkin Lymphoma Over 10 Years at a Tertiary Center in Cape Town, South Africa.

[10] High in vitro and in vivo antitumor activities of luminecent platinum(II) complexes with jatrorrhizine derivatives.

[11] [Effect on p53 and caspase-3 of hippocampal neuron in the rats with cerebral ischemia-reperfusion injury treated with electroacupuncture preconditioning at the acupoints on the basis of and relationship].

[12] The Mitochondrial Protein MAVS Stabilizes p53 to Suppress Tumorigenesis.

[13] Association of dietary intake of fruit and green Vegetables with PTEN and P53 mRNA gene expression in visceral and subcutaneous adipose tissues of obese and non-obese adults.

[14] In-situ-Formed PdFe Nanoalloy and Carbon Defects in Cathode for Synergic Reduction-Oxidation of Chlorinated Pollutants in Electro-Fenton Process.

[15] Balancing water sustainability and productivity objectives in microalgae cultivation: Siting open ponds by considering seasonal water-stress impact using AWARE-US.

[16] Differential work-function enabled bifunctional switching in strontium titanate flexible resistive memories.

[17] Role of RUNX Family Transcription Factors in DNA Damage Response.

[18] The RB gene family controls the maturation state of the EndoC-βH2 human pancreatic β-cells.

[19] Involvement of p53 acetylation in growth suppression of Cutaneous T-cell lymphomas induced by HDAC inhibition.

[20] Quantitative Transcriptional Biomarkers of Xenobiotic Receptor Activation in Rat Liver for The Early Assessment of Drug Safety Liabilities.

[21] Pilosebaceous Malignant Transformation of Dermoid Cyst in the Orbit.

[22] Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma.

[23] Corrigendum to: SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21 , cyclin D1 and β-catenin.

[24] Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway.

[25] TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies.

[26] Cyclin D1, Caspase 9 and P53 Expressions in T47D Cell Lines after Treatment of , (Lour.) Spreng. Leaves Ethanolic Extract Nanoparticles.

[27] Substitution at Phenyl Rings of Chalcone and Schiff Base Moieties Accounts for their Antiproliferative Activity.

[28] Autophagy promotes mammalian survival by suppressing oxidative stress and p53.

[29] The Evolutionary Origins of Recurrent Pancreatic Cancer.

[30] Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.

[31] metastatic prolactinoma: case report with immunohistochemical assessment for p53 and ki-67 antigens prolactinoma metastático: relato de caso com avaliação imuno-histoquímica para os antígenos p53 e ki-67

[32] temporally distinct roles for tumor suppressor pathways in cell cycle arrest and cellular senescence in cyclin d1-driven tumor

[33] cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells

[34] utilization of microsatellites for the analysis of genomic alterations in colorectal cancers in brazil

[35] immunohistochemical study of p53 expression in patients with erosive and non-erosive oral lichen planus

[36] high expression of p53 protein in recurrent pregnancy loss could play a role in the pathology!!

[37] fludarabine induces apoptosis in chronic lymphocytic leukemia - the role of p53, bcl-2, bax, mcl-1, and bag-1 proteins

[38] "Pelargonidin mediated selective activation of p53 and PARP proteins in preventing food additive induced genotoxicity: an in vivo coupled in silico molecular docking study".

[39] the promise of agriculture genomics

[40] cape analogs induce growth arrest and apoptosis in breast cancer cells

[41] reactive oxygen species, superoxide dimutases, and pten-p53-akt-mdm2 signaling loop network in mesenchymal stem/stromal cells regulation

[42] ultrasound molecular imaging of breast cancer in mcf-7 orthotopic mice using gold nanoshelled poly(lactic-co-glycolic acid) nanocapsules: a novel dual-targeted ultrasound contrast agent

[43] the contrived mutant p53 oncogene – beyond loss of functions

[44] p53 calls upon cia (calcium induced apoptosis) to counter stress

[45] prostate cancer and li-fraumeni syndrome: implications for screening and therapy

[46] cancer chemoprevention by resveratrol: the p53 tumor suppressor protein as a promising molecular target

[47] p53/surviving ratio as a parameter for chemotherapy induction response in children with acute myeloid leukemia

[48] electroacupuncture restores locomotor functions after mouse spinal cord injury in correlation with reduction of pten and p53 expression

[49] insights of crosstalk between p53 protein and the mkk3/mkk6/p38 mapk signaling pathway in cancer

[50] cap-independent translational control of carcinogenesis

[51] p53 and mdm2 protein expression in actinic cheilitis

[52] hypoxia-induced cisplatin resistance in non-small cell lung cancer cells is mediated by hif-1α and mutant p53 and can be overcome by induction of oxidative stress

[53] genotoxicity of cytolethal distending toxin (cdt) on isogenic human colorectal cell lines: potential promoting effects for colorectal carcinogenesis

[54] activation of p53 with ilimaquinone and ethylsmenoquinone, marine sponge metabolites, induces apoptosis and autophagy in colon cancer cells

[55] Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents.

[56] Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition

[57] Inotodiol inhibits cells migration and invasion and induces apoptosis via p53-dependent pathway in HeLa cells.

[58] Fluorometric determination of the p53 cancer gene using strand displacement amplification on gold nanoparticles.

[59] Frequent mutations in EGFR, KRAS and TP53 genes in human lung cancer tumors detected by ion torrent DNA sequencing.

[60] Synthesis, Biological and In Silico Evaluation of Pure Nucleobase-Containing Spiro (Indane-Isoxazolidine) Derivatives as Potential Inhibitors of MDM2–p53 Interaction

[61] Nuclear-targeted p53 and DOX co-delivery of chitosan derivatives for cancer therapy in vitro and in vivo.

[62] Dysregulation of p53 and Parkin Induce Mitochondrial Dysfunction and Leads to the Diabetic Neuropathic Pain

[63] Correction: Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells.

[64] Contribution of time delays to p53 oscillation in DNA damage response.

[65] Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles

[66] A Substantial Proportion of Apparently Heterozygous TP53 Pathogenic Variants Detected with a Next-Generation Sequencing Hereditary Pan-Cancer Panel Are Acquired Somatically.

[67] Down-regulation of cyclin-dependent kinase 5 attenuates p53-dependent apoptosis of hippocampal CA1 pyramidal neurons following transient cerebral ischemia.

[68] p53 pulse modulation differentially regulates target gene promoters to regulate cell fate decisions.

[69] A tumor-targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma

[70] Disordered p53-MALAT1 pathway is associated with recurrent miscarriage.

[71] Effect of p53 Arg72Pro polymorphism on the induction of micronucleus by aflatoxin B1 in in vitro in human blood lymphocytes.

[72] Extracorporeal shock waves protect cardiomyocytes from doxorubicin-induced cardiomyopathy by upregulating survivin via the integrin-ILK-Akt-Sp1/p53 axis

[73] Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity

[74] Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer

[75] The role of acetylation sites in the regulation of p53 activity.

[76] HDAC inhibition induces expression of scaffolding proteins critical for tumor progression in pediatric glioma: focus on EBP50 and IRSp53.

[77] The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.

[78] Molecular and clinical features of the TP53 signature gene expression profile in early-stage breast cancer

[79] Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.

[80] TGF-β1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications.

[81] [Effect on p53 and caspase-3 of hippocampal neuron in the rats with cerebral ischemia-reperfusion injury treated with electroacupuncture preconditioning at the acupoints on the basis of and relationship].

[82] The Mitochondrial Protein MAVS Stabilizes p53 to Suppress Tumorigenesis.

[83] Association of dietary intake of fruit and green Vegetables with PTEN and P53 mRNA gene expression in visceral and subcutaneous adipose tissues of obese and non-obese adults.

[84] A novel TRIM family member, Trim69, regulates zebrafish development through p53-mediated apoptosis.

[85] Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway

[86] Variation in Presentation and Presence of DNA Adducts and p53 Mutations in Patients with Endemic Nephropathy - an Environmental Form of the Aristolochic Acid Nephropathy

[87] High Expression of CARM1 Inhibits Lung Cancer Progression by Targeting TP53 by Regulating CTNNB1.

[88] Replica to the Opinion Letter regarding the article “Sensitization of colorectal cancer cells to irinotecan by the Survivin inhibitor LLP3 depends on XAF1 proficiency in the context of mutated p53” (Arch Toxicol https://doi.org/10.1007/s00204-018-240-x)

[89] Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer

[90] Antiproliferative activity of di-2-pyridylhydrazone dithiocarbamate acetate partly involved in p53 mediated apoptosis and autophagy.

[91] TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort.

[92] p53-cyclophilin D mediates renal tubular cell apoptosis in ischemia-reperfusion-induced acute kidney injury

[93] Ribosomal DNA copy number is associated with P53 status and levels of heavy metals in gastrectomy specimens from gastric cancer patients.

[94] Involvement of p53 acetylation in growth suppression of Cutaneous T-cell lymphomas induced by HDAC inhibition.

[95] Corrigendum to: SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21 , cyclin D1 and β-catenin.

[96] Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway.

[97] Organ-specific regulation of CHD1 by acute PTEN and p53 loss in mice.

[98] TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies.

[99] TAK1 signaling regulates p53 through a mechanism involving ribosomal stress

[100] β-Actin facilitates etoposide-induced p53 nuclear import

[101] p53 dynamics in single cells are temperature-sensitive